Header Logo

Connection

RACHELLE DOODY to Clinical Trials as Topic

Back to Details
This is a "connection" page, showing publications RACHELLE DOODY has written about Clinical Trials as Topic.
RACHELLE DOODY
Connection Strength
2.125
Clinical Trials as Topic
  1. Global issues in drug development for Alzheimer's disease. Alzheimers Dement. 2011 Mar; 7(2):197-207.
    View in: PubMed
    Score: 0.266
  2. [Clinical trials in AD]. Rinsho Shinkeigaku. 2010 Nov; 50(11):835.
    View in: PubMed
    Score: 0.260
  3. Evolving early (pre-dementia) Alzheimer's disease trials: suit the outcomes to the population and study design. J Nutr Health Aging. 2010 Apr; 14(4):299-302.
    View in: PubMed
    Score: 0.250
  4. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Recruitment of participants for Alzheimer's disease clinical trials: the role of trust in caregivers, clinical researchers, regulatory authorities, and industry sponsors. Alzheimers Dement. 2009 Mar; 5(2):122-4.
    View in: PubMed
    Score: 0.232
  5. We should not distinguish between symptomatic and disease-modifying treatments in Alzheimer's disease drug development. Alzheimers Dement. 2008 Jan; 4(1 Suppl 1):S21-5.
    View in: PubMed
    Score: 0.213
  6. Viewpoint: The Role of Futility Analyses in Alzheimer's Disease Clinical Trials. J Prev Alzheimers Dis. 2020; 7(1):7.
    View in: PubMed
    Score: 0.123
  7. The Future of Anti-Amyloid Trials. J Prev Alzheimers Dis. 2020; 7(3):146-151.
    View in: PubMed
    Score: 0.123
  8. EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials. J Prev Alzheimers Dis. 2017; 4(2):116-124.
    View in: PubMed
    Score: 0.100
  9. Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials. Parkinsonism Relat Disord. 2016 07; 28:41-48.
    View in: PubMed
    Score: 0.095
  10. Report of the task force on designing clinical trials in early (predementia) AD. Neurology. 2011 Jan 18; 76(3):280-6.
    View in: PubMed
    Score: 0.066
  11. A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement. 2009 Mar; 5(2):85-92.
    View in: PubMed
    Score: 0.058
  12. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease. Alzheimers Dement. 2009 Mar; 5(2):133-6.
    View in: PubMed
    Score: 0.058
  13. Disease-modifying therapies for Alzheimer disease: challenges to early intervention. Neurology. 2007 Oct 16; 69(16):1622-34.
    View in: PubMed
    Score: 0.053
  14. Refining treatment guidelines in Alzheimer's disease. Geriatrics. 2005 Jun; Suppl:14-20.
    View in: PubMed
    Score: 0.045
  15. Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force. J Prev Alzheimers Dis. 2024; 11(5):1219-1227.
    View in: PubMed
    Score: 0.041
  16. Current treatments for Alzheimer's disease: cholinesterase inhibitors. J Clin Psychiatry. 2003; 64 Suppl 9:11-7.
    View in: PubMed
    Score: 0.038
  17. Clinical benefits of a new piperidine-class AChE inhibitor. Eur Neuropsychopharmacol. 1999 Apr; 9 Suppl 2:S69-77.
    View in: PubMed
    Score: 0.029
  18. Alzheimer disease-related activities in China: a report from the International Working Group on the Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1998 Dec; 12(4):263-5.
    View in: PubMed
    Score: 0.028
  19. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement. 2008 May; 4(3):156-63.
    View in: PubMed
    Score: 0.014
  20. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004 Jan; 61(1):59-66.
    View in: PubMed
    Score: 0.010
  21. Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 3:8-18.
    View in: PubMed
    Score: 0.006
  22. Cultural issues in the clinical diagnosis of Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 3:19-21.
    View in: PubMed
    Score: 0.006
  23. Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 3:22-5.
    View in: PubMed
    Score: 0.006
  24. Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 3:46-9.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.